Tobramycin once- vs thrice-daily for elective intravenous antipseudomonal therapy in pediatric cystic fibrosis patients

被引：0
|
作者：
J. Riethmueller
M. Ballmann
T. W. Schroeter
P. Franke
R. von Butler
A. Claass
S. Junge
G. Doering
M. Stern
机构：
[1] University Children’s Hospital,Pediatric Dept.
[2] University Children’s Hospital Kiel,undefined
[3] University of Hannover,undefined
[4] Hygiene-Institut,undefined
[5] University of Tübingen,undefined
来源：
Infection | 2009年 / 37卷
关键词：
Ceftazidime; Tobramycin; Cystic Fibrosis Patient; Postantibiotic Effect; Multiple Daily Dose;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：424 / 431
页数：7
相关论文
共 48 条
  • [41] Oral ciprofloxacin vs. intravenous ceftazidime plus tobramycin in pediatric cystic fibrosis patients: Comparison of antipseudomonas efficacy and assessment of safety with ultrasonography and magnetic resonance imaging
    Richard, DA
    NousiaArvanitakis, S
    Sollich, V
    Hampel, BJ
    Sommerauer, B
    Schaad, UB
    Sardet, A
    Bromme, S
    Kloditz, E
    Lietz, T
    Schille, R
    Posselt, HG
    Noll, S
    Zimmermann, T
    BarmeierWasmuth, H
    Wahn, U
    Weber, A
    Magdorf, K
    Wacker, F
    Troger, J
    Lyle, M
    Schmidt, A
    Preuss, I
    Krasemann, C
    Nikolaidis, P
    Peonides, A
    Skalidopoulos, S
    Sotiriadis, G
    Gyurkovits, K
    Bolbas, K
    Rivlin, J
    Mastella, G
    Cipolli, M
    Trogu, P
    Barreto, C
    Lara, E
    Egner, J
    Hauptmann, M
    Wedgwood, J
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (06) : 572 - 578
  • [42] Comparison of thrice-daily premixed insulin (insulin lispro premix) with basal-bolus (insulin glargine once-daily plus thrice-daily prandial insulin lispro) therapy in east Asian patients with type 2 diabetes insufficiently controlled with twice-daily premixed insulin: an open-label, randomised, controlled trial
    Jia, Weiping
    Xiao, Xinhua
    Ji, Qiuhe
    Ahn, Kyu-Jeung
    Chuang, Lee-Ming
    Bao, Yuqian
    Pang, Can
    Chen, Lei
    Gao, Fei
    Tu, Yinfang
    Li, Pengfei
    Yang, Jun
    LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (04): : 254 - 262
  • [43] Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis
    Terpstra, Lotte C. C.
    Altenburg, Josje
    Bronsveld, Inez
    de Kruif, Martijn D. D.
    Berk, Yvonne
    Snijders, Dominic
    Rozemeijer, Wouter
    Heijerman, Harry G. M.
    Boersma, Wim G. G.
    RESPIRATORY RESEARCH, 2022, 23 (01)
  • [44] Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis
    Lotte C. Terpstra
    Josje Altenburg
    Inez Bronsveld
    Martijn D. de Kruif
    Yvonne Berk
    Dominic Snijders
    Wouter Rozemeijer
    Harry G. M. Heijerman
    Wim G. Boersma
    Respiratory Research, 23
  • [45] Late Breaking Abstract - Effects of long-term Tobramycin Inhalation Solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis. The BATTLE Randomized Controlled Trial
    Terpstra, Lotte
    Bronsveld, Inez
    Doodeman, Jeroen
    Rozenmeijer, Wouter
    Heijerman, Harry
    Boersma, Wim
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [46] An impulse oscillometry system is less efficient than spirometry in tracking lung function improvements after intravenous antibiotic therapy in pediatric patients with cystic fibrosis
    Buchs, Clelia
    Coutier, Laurianne
    Vrielynck, Stephanie
    Jubin, Virginie
    Mainguy, Catherine
    Reix, Philippe
    PEDIATRIC PULMONOLOGY, 2015, 50 (11) : 1073 - 1081
  • [47] Study Design: Effects Of Long Term Tobramycin Inhalation Solution (tis) Once Daily On Exacerbation Rate In Patients With Non-Cystic Fibrosis Bronchiectasis. A Double Blind, Randomized, Placebo And Tis Twice Daily (open Label) Controlled Trial. The Battle Study
    Terpstra, L.
    Altenburg, J.
    Duijkers, R.
    Boersma, W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [48] The BATTLE study: Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis. Study protocol of a double blind, randomized, placebo-controlled trial: study protocol
    Terpstra, L. C.
    Altenburg, J.
    Bronsveld, I.
    Doodeman, H. J.
    Rozemeijer, W.
    Heijerman, H. G. M.
    Boersma, W. G.
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2022, 30
12345